Bayer Receives FDA Endorsement to Accelerate Development of Parkinson Treatment
Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.
Scientists Just Found a Cholesterol Clue That Could Change Parkinson’s Treatment
A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...
Becker's Hospital Review16h
AI helps Cleveland Clinic uncover new uses for existing drugs
Cleveland Clinic researchers are using artificial intelligence to identify existing FDA-approved drugs that may be repurposed to treat other complex diseases. The effort is led by Feixiong Cheng, PhD, ...
Cholesterol metabolism byproduct linked to Parkinson's disease
Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical ...